Hua Medicine

Hua Medicine is a leading clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Founded by pharma industry veterans and funded by a premier group of international VC investment firms such as Fidelity Asia, Fidelity Biosciences, ARCH Ventures, Venrock, SAIL and WuXi Ventures, the company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action.
Company Growth (employees)
Type
Private
HQ
Shanghai, CN
Size (employees)
14 (est)+17%
Hua Medicine is headquartered in Shanghai, CN

Key People at Hua Medicine

Li Chen

Li Chen

President and CEO

Hua Medicine Office Locations

Hua Medicine has an office in Shanghai

Hua Medicine Metrics

Summary Metrics

Hua Medicine's latest funding round in April 2016 was reported to be $50 m. In total, Hua Medicine has raised $125 m

Hua Medicine Company Life

You may also be interested in